HC Starck Intention to Buy into Fuel Cell Producer

HC Starck have signed a non-binding letter of agreement to acquire a majority shareholding in InDEC BV (The Netherlands). Other shareholders in InDEC include ECN and Planet Capital. The letter signed on November 12 also gives them the option of acquiring the remainder of InDEC at a later date.

HC Starck intend to use the investment as a door into the solid oxide fuel cells market. They will contribute their knowledge and experience in the area of commercialising high-tech products in fast growing markets. This will in turn enable InDEC to set itself up as a key supplier of solid oxide fuel cells to stack and system developing industries.

If the transaction proceeds, it is envisages that InDEC and ECN will enter into a research and development programme to improve current fuel cells and develop new ones.

:

For more information on fuel cells, click here.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    HC Starck Tungsten GmbH. (2023, April 21). HC Starck Intention to Buy into Fuel Cell Producer. AZoM. Retrieved on April 21, 2024 from https://www.azom.com/news.aspx?newsID=377.

  • MLA

    HC Starck Tungsten GmbH. "HC Starck Intention to Buy into Fuel Cell Producer". AZoM. 21 April 2024. <https://www.azom.com/news.aspx?newsID=377>.

  • Chicago

    HC Starck Tungsten GmbH. "HC Starck Intention to Buy into Fuel Cell Producer". AZoM. https://www.azom.com/news.aspx?newsID=377. (accessed April 21, 2024).

  • Harvard

    HC Starck Tungsten GmbH. 2023. HC Starck Intention to Buy into Fuel Cell Producer. AZoM, viewed 21 April 2024, https://www.azom.com/news.aspx?newsID=377.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.